← Back to Search

CRP + S&A for Substance Use Disorders (CRP and S&A Trial)

N/A
Recruiting
Led By Elizabeth J. Santa Ana, PhD MA BA
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Willing to commit to 6 group inpatient therapy sessions, telehealth S&A, as well as baseline, and 1-and 3-month follow-up assessments
Functioning at an intellectual level sufficient to allow accurate completion of all assessments
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 month
Awards & highlights

CRP and S&A Trial Summary

This trial is testing three different treatments to help improve outcomes for people with substance abuse problems. Veterans at the Charleston VA Psychiatric inpatient unit who are admitted may be invited to participate.

Who is the study for?
This trial is for veterans with substance use problems who are inpatients at the Charleston VA Psychiatric unit. Participants must understand English, be able to consent, complete assessments, and commit to therapy sessions and follow-ups. They should have used substances within the last 30 days and meet criteria for a current substance use disorder.Check my eligibility
What is being tested?
The study compares three treatments: Combined Recovery Program (CRP) with six group sessions on the unit; Stable & Able (S&A), a telehealth program before discharge providing support up to 3 months; and Treatment-as-usual (TAU), which includes various recovery-related mental health topics.See study design
What are the potential side effects?
Since this trial involves psychological therapies rather than medications, traditional side effects like those seen with drugs are not expected. However, participants may experience emotional discomfort or distress during therapy.

CRP and S&A Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am willing to attend 6 therapy sessions and follow-up assessments.
Select...
I can understand and complete all required tests and questionnaires.

CRP and S&A Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol Drink Days at 1 Month
Alcohol Drink Days at 3 Month
Alcohol Drink Days at Baseline
+24 more
Secondary outcome measures
Addiction Severity Index-Lite (ASI-Lite) at 1 month for Alcohol Use
Addiction Severity Index-Lite (ASI-Lite) at 1 month for Psychiatric Status
Alcohol Use Disorder
+22 more

CRP and S&A Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Combined Recovery Program (CRP)+Treatment-as-usual (TAU)Experimental Treatment1 Intervention
Combined Recovery Program (CRP) is a six-session motivational enhancement and daily living skills therapy workshop provided while on the inpatient unit. Attendance of CRP will be in addition to Treatment as Usual (TAU), that is, standard inpatient programming.
Group II: CRP+ Stable & Able (S&A)+TAUActive Control2 Interventions
Combined Recovery Program (CRP) a six-session motivational enhancement and daily living skills therapy workshop provided while on the inpatient unit, plus a home telehealth program (Stable & Able) which begins on day 1 of hospital discharge. Attendance of CRP and S&A will be in addition to TAU, that is, standard inpatient programming.
Group III: Treatment-as-usual only (TAU):Active Control1 Intervention
TAU will only receive the usual care on the inpatient unit including medical and medication management.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,607 Previous Clinical Trials
3,305,840 Total Patients Enrolled
Elizabeth J. Santa Ana, PhD MA BAPrincipal InvestigatorRalph H. Johnson VA Medical Center, Charleston, SC
2 Previous Clinical Trials
365 Total Patients Enrolled

Media Library

Combined Recovery Program Clinical Trial Eligibility Overview. Trial Name: NCT05054738 — N/A
Substance Use Disorders Research Study Groups: Combined Recovery Program (CRP)+Treatment-as-usual (TAU), CRP+ Stable & Able (S&A)+TAU, Treatment-as-usual only (TAU):
Substance Use Disorders Clinical Trial 2023: Combined Recovery Program Highlights & Side Effects. Trial Name: NCT05054738 — N/A
Combined Recovery Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05054738 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must one meet to be included in this research study?

"This clinical trial seeks 195 patients aged 18-75 with dual diagnosis. To qualify, participants must have used substances within 30 days prior to the inpatient admission date and be willing to commit to 6 group therapy sessions, telehealth assessments & screenings, as well as baseline and 1-3 month follow up tests. Additionally, they should possess a level of intellectual functioning that allows them to accurately complete all required assessments."

Answered by AI

What is the present scope of participants involved in this experiment?

"Affirmative. The clinicaltrial.gov website reveals that this medical study, initiated on September 6th 2022, is presently recruiting 195 individuals from a single centre."

Answered by AI

Is this experiment open to elderly individuals?

"This clinical trial has a predetermined age range for enrollment, with the lower limit set at 18 and the upper limit set at 75."

Answered by AI

Are participants being enrolled in this research currently?

"Affirmative. Clinicaltrials.gov has the most recent records which show that this clinical trial, initiated on September 6th 2022, is presently recruiting participants. 195 individuals are required to join from 1 location."

Answered by AI

What effects are researchers predicting from this clinical trial?

"Over 3 months, this clinical trial will monitor Twelve-Step Sessions Attended in order to achieve its primary objective. Secondary objectives include the Addiction Severity Index-Lite (ASI-Lite) for Alcohol Use with a score range of 0 - 1 being measured at the same time frame; Treatment Motivation Questionnaire (TMQ), which has two subscales averaging scores between 1 and 7 wherein higher values indicate more external or internal motivations respectively; as well as Short Inventory of Problems (SIP) from baseline with 45 being the maximum value showing greater consequences from drug/alcohol use."

Answered by AI
~82 spots leftby May 2025